(VIANEWS) – Shares of Sorrento Therapeutics (SRNE) fell by a staggering 25.3% in 30 days from $10.99 to $8.21 at 16:16 EST on Saturday, following the last session’s downward trend. NASDAQ Composite is sliding 0.71% to $14,672.68, following the last session’s downward trend.

Sorrento Therapeutics’s last close was $8.39, 56.73% below its 52-week high of $19.39.


Today’s last reported volume for Sorrento Therapeutics is 2711185 which is 60.61% below its average volume of 6882504.

Sorrento Therapeutics’s Sales

Sorrento Therapeutics’s sales growth is 53.9% for the current quarter and 56.4% for the next. The company’s growth estimates for the current quarter and the next is 52.8% and 45.5%, respectively.

Sorrento Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 84.6%, now sitting on 46.52M for the twelve trailing months.


Sorrento Therapeutics’s last week, last month’s, and last quarter’s current volatility was a negative 0.64%, a negative 0.64%, and a positive 3.82%, respectively.

Sorrento Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.67% (last week), 4.78% (last month), and 3.82% (last quarter), respectively.

Sorrento Therapeutics’s Stock Yearly Top and Bottom Value

Sorrento Therapeutics’s stock is valued at $8.21 at 16:16 EST, way under its 52-week high of $19.39 and way above its 52-week low of $5.17.

Sorrento Therapeutics’s Moving Average

Sorrento Therapeutics’s worth is below its 50-day moving average of $8.88 and way below its 200-day moving average of $9.23.

More news about Sorrento Therapeutics (SRNE).


Please enter your comment!
Please enter your name here